Top

Gepubliceerd in:

2021 | OriginalPaper | Hoofdstuk

21. Slaapstoornissen bij ouderen

Auteurs : dr. Julia van den Berg, dr. Viona Wijnen, dr. Saskia van Liempt

Gepubliceerd in: Slaapstoornissen in de psychiatrie

Uitgeverij: Bohn Stafleu van Loghum

Samenvatting

Goed slapen is ook voor ouderen van groot belang voor de mentale en lichamelijke gezondheid. Slaapstoornissen komen vaker voor bij ouderen dan bij jongere volwassenen, maar zijn geen vanzelfsprekend onderdeel van het verouderingsproces. Na goede diagnostiek is verbetering van de slaap dan ook vaak mogelijk. Oorzaken van de hogere prevalentie van slaapstoornissen zijn onder andere neurobiologische factoren, het vaker voorkomen van somatische problemen, medicatiegebruik, weinig lichtblootstelling en psychosociale factoren. Insomnie is ook bij ouderen de meest voorkomende slaapstoornis. Bij insomnie is, volgens internationale richtlijnen, ook voor ouderen cognitieve gedragstherapie bij insomnie (CGT-i) de beste en veiligste behandelvorm. Het medicamenteus behandelen van chronische insomnie moet bij ouderen met grote terughoudendheid en voorzichtigheid gedaan worden, wegens mogelijk ernstige bijwerkingen. Dementie en delier gaan meestal samen met gestoorde slaap; voor deze doelgroep is een individuele CGT-i vaak niet geschikt, maar andere niet-medicamenteuze interventies, met name lichtblootstelling en een regelmatig ritme, zijn wel mogelijk.

vorige hoofdstuk Slaapproblemen bij kinderen en jeugdigen

volgende hoofdstuk Slaap en verstandelijke beperking

Ángeles-Castellanos, M., Ramírez-Gonzalez, F., Ubaldo-Reyes, L., Rodriguez-Mayoral, O., & Escobar, C. (2016). Loss of melatonin daily rhythmicity is asociated with delirium development in hospitalized older adults. Sleep Science. https://doi.org/10.1016/j.slsci.2016.08.001.CrossRefPubMedPubMedCentral

Auld, F., Maschauer, E. L., Morrison, I., Skene, D. J., & Riha, R. L. (2017). Evidence for the efficacy of melatonin in the treatment of primary adult sleep disorders. Sleep Medicine Reviews, 34, 10–22. https://doi.org/10.1016/j.smrv.2016.06.005.CrossRefPubMed

Bachman, D., & Rabins, P. (2006). ‘Sundowning’ and other temporally associated agitation states in dementia patients. Annual Review of Medicine, 57(1), 499–511. https://doi.org/10.1146/annurev.med.57.071604.141451.CrossRefPubMed

Bannon, L., Mcgaughey, J., Verghis, R., Clarke, M., Mcauley, D. F., & Blackwood, B. (2019). The effectiveness of non-pharmacological interventions in reducing the incidence and duration of delirium in critically ill patients: A systematic review and meta-analysis. Intensive Care Medicine, 45, 1–12. https://doi.org/10.1007/s00134-018-5452-x.CrossRefPubMed

Baumgartner, L., Lam, K., Lai, J., Barnett, M., Thompson, A., Gross, K., et al. (2019). Effectiveness of melatonin for the prevention of intensive care unit delirium. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 39(3), 280–287. https://doi.org/10.1002/phar.2222.

Beaulieu-Bonneau, S., Ivers, H., Guay, B., & Morin, C. M. (2017). Long-term maintenance of therapeutic gains associated with cognitive-behavioral therapy for insomnia delivered alone or combined with zolpidem. Sleep, 40(3). https://doi.org/10.1093/sleep/zsx002.

Bernert, R. A., Turvey, C. L., Conwell, Y., & Joiner, T. E., Jr. (2014). Association of poor subjective sleep quality with risk for death by suicide during a 10-year period: A longitudinal, population-based study of late life. JAMA Psychiatry, 71(10), 1129–1137. https://doi.org/10.1001/jamapsychiatry.2014.1126.CrossRefPubMedPubMedCentral

Bloom, H. G., Ahmed, I., Alessi, C. A., Ancoli-Israel, S., Buysse, D. J., Kryger, M. H., et al. (2009). Evidence-based recommendations for the assessment and management of sleep disorders in older persons: Supplement. Journal of the American Geriatrics Society, 57(5), 761789. https://doi.org/10.1111/j.1532-5415.2009.02220.x.CrossRef

Brenes, G. A., Miller, M. E., Stanley, M. A., Williamson, J. D., Knudson, M., & McCall, W. V. (2009). Insomnia in older adults with generalized anxiety disorder. The American Journal of Geriatric Psychiatry, 17(6), 465–472. https://doi.org/10.1097/JGP.0b013e3181987747.CrossRefPubMedPubMedCentral

Buscemi, N., Vandermeer, B., Hooton, N., Pandya, R., Tjosvold, L., Hartling, L., et al. (2006). Efficacy and safety of exogenous melatonin for secondary sleep disorders and sleep disorders accompanying sleep restriction: Meta-analysis. British Medical Journal, 332(7538), 385–388. https://doi.org/10.1136/bmj.38731.532766.F6.CrossRefPubMed

Buysse, D. J., Germain, A., Moul, D. E., Franzen, P. L., Brar, L. K., Fletcher, M. E., et al. (2011). Efficacy of brief behavioral treatment for chronic insomnia in older adults. Archives of Internal Medicine, 171(10), 887–895. https://doi.org/10.1001/archinternmed.2010.535.CrossRefPubMedPubMedCentral

Christensen, H., Jorm, A. F., Mackinnon, A. J., Korten, A. E., Jacomb, P. A., Henderson, A. S., et al. (1999). Age differences in depression and anxiety symptoms: A structural equation modelling analysis of data from a general population sample. Psychological Medicine, 29(2), 325–339. https://doi.org/10.1017/S0033291798008150.CrossRefPubMed

De Jonghe, A., Korevaar, J. C., Van Munster, B. C., & De Rooij, S. E. (2010). Effectiveness of melatonin treatment on circadian rhythm disturbances in dementia. Are there implications for delirium? A systematic review. International Journal of Geriatric Psychiatry, 25(12), 1201–1208. https://doi.org/10.1002/gps.2454.

De Rooij, S. E., & Van Munster, B. C. (2013). Melatonin deficiency hypothesis in delirium: A synthesis of current evidence. Rejuvenation Research, 16(4). https://doi.org/10.1089/rej.2012.1405.

Dzierzewski, J. M., Martin, J. L., Fung, C. H., Song, Y., Fiorentino, L., Jouldjian, S., et al. (2019). CBT for late-life insomnia and the accuracy of sleep and wake perceptions: Results from a randomized-controlled trial. Journal of Sleep Research, 28(4). https://doi.org/10.1111/jsr.12809.

Feng, R., Li, L., Yu, H., Liu, M., & Zhao, W. (2016). Melanopsin retinal ganglion cell loss and circadian dysfunction in Alzheimer’s disease (Review). Molecular Medicine Reports, 13(4), 3397–3400. https://doi.org/10.3892/mmr.2016.4966.CrossRefPubMedPubMedCentral

Figueiro, M. (2008). A proposed 24 h lighting scheme for older adults. Lighting Research & Technology, 40(2), 153–160. https://doi.org/10.1177/1477153507087299.CrossRef

Figueiro, M. G. (2017). Light, sleep and circadian rhythms in older adults with Alzheimer’s disease and related dementias. Neurodegenerative Disease Management, 7(2), 119–145. https://doi.org/10.2217/nmt-2016-0060.CrossRefPubMedPubMedCentral

Fitzgerald, J. M., Adamis, D., Trzepacz, P. T., O’Regan, N., Timmons, S., Dunne, C., et al. (2013). Delirium: A disturbance of circadian integrity? Medical Hypotheses, 81(4), 568–576. https://doi.org/10.1016/j.mehy.2013.06.032.CrossRefPubMed

FitzGerald, J. M., O’Regan, N., Adamis, D., Timmons, S., Dunne, C. P., Trzepacz, P. T., et al. (2017). Sleep-wake cycle disturbances in elderly acute general medical inpatients: Longitudinal relationship to delirium and dementia. Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring, 7, 61–68. https://doi.org/10.1016/j.dadm.2016.12.013.CrossRef

Foley, D. J., Monjan, A., Brown, S. L., Simonsick, E. M., Wallace, B., & Blazer, G. (1995). Sleep complaints among elderly persons: An epidemiologic study of three communities. Sleep, 18(6), 425–432. https://doi.org/10.1093/sleep/18.6.425.CrossRefPubMed

Foley, D. J., Vitiello, M. V., Bliwise, D. L., Ancoli-Israel, S., Monjan, A. A., & Walsh, J. K. (2007). Frequent napping is associated with excessive daytime sleepiness, depression, pain, and nocturia in older adults: Findings from the National Sleep Foundation “2003 Sleep in America” poll. The American Journal of Geriatric Psychiatry, 15(4), 344–350.CrossRef

Forbes, D., Blake, C. M., Thiessen, E. J., Peacock, S., & Hawranik, P. (2014). Light therapy for improving cognition, activities of daily living, sleep, challenging behaviour, and psychiatric disturbances in dementia. Cochrane Database of Systematic Reviews, (2), CD003946. https://doi.org/10.1002/14651858.CD003946.pub4.

Glass, J., Lanctôt, K. L., Herrmann, N., Sproule, B. A., & Busto, U. E. (2005). Sedative hypnotics in older people with insomnia: Meta-analysis of risks and benefits. British Medical Journal, 331(7526), 1169–1173. https://doi.org/10.1136/bmj.38623.768588.47.CrossRefPubMed

Groves, R. L. (2019). Increasing light exposure for the prevention of delirium. Dimensions of Critical Care Nursing, 38(2), 96–107. https://doi.org/10.1097/DCC.0000000000000343.CrossRefPubMed

Hartmaier, S. L., Sloane, P. D., Guess, H. A., Koch, G. G., Mitchell, C. M., & Phillips, C. D. (1995). Validation of the minimum data set cognitive performance scale: Agreement with the mini-mental state examination. Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 50(2), M128–M133.

Howell, M. J., & Schenck, C. H. (2015). Rapid eyemovement sleep behavior disorder and neurodegenerative disease. JAMA Neurology, 72(6), 707–712. https://doi.org/10.1001/jamaneurol.2014.4563.CrossRefPubMed

Kondratova, A. A., & Kondratov, R. V. (2012). The circadian clock and pathology of the ageing brain. Nature Reviews Neuroscience, 13(5), 325–335. https://doi.org/10.1038/nrn3208.CrossRefPubMedPubMedCentral

Krystal, A. D., Durrence, H. H., Scharf, M., Jochelson, P., Rogowski, R., Ludington, E., et al. (2010). Efficacy and safety of doxepin 1 mg and 3 mg in a 12-week sleep laboratory and outpatient trial of elderly subjects with chronic primary insomnia. Sleep, 33(11), 1553–1561. https://doi.org/10.1093/sleep/33.11.1553.CrossRefPubMedPubMedCentral

La Morgia, C., Ross-Cisneros, F. N., Koronyo, Y., Hannibal, J., Gallassi, R., Cantalupo, G., et al. (2016). Melanopsin retinal ganglion cell loss in Alzheimer disease. Annals of Neurology, 79(1), 90–109. https://doi.org/10.1002/ana.24548.CrossRefPubMed

La Morgia, C., Ross-Cisneros, F. N., Sadun, A. A., & Carelli, V. (2017). Retinal ganglion cells and circadian rhythms in Alzheimer’s disease, Parkinson’s disease, and beyond. Frontiers in Neurology, 8, 162. https://doi.org/10.3389/fneur.2017.00162.CrossRefPubMedPubMedCentral

Lankford, A., Rogowski, R., Essink, B., Ludington, E., Heith Durrence, H., & Roth, T. (2012). Efficacy and safety of doxepin 6 mg in a four-week outpatient trial of elderly adults with chronic primary insomnia. Sleep Medicine, 13(2), 133–138. https://doi.org/10.1016/J.SLEEP.2011.09.006.CrossRefPubMed

Lund, H. G., Rybarczyk, B. D., Perrin, P. B., Leszczyszyn, D., & Stepanski, E. (2013). The discrepancy between subjective and objective measures of sleep in older adults receiving cbt for comorbid insomnia. Journal of Clinical Psychology, 69(10), 1108–1120. https://doi.org/10.1002/jclp.21938.CrossRefPubMed

Mallon, L., Broman, J.-E., Åkerstedt, T., & Hetta, J. (2014). Insomnia in Sweden: A population-based survey. Sleep Disorders, 2014, 1–7. https://doi.org/10.1155/2014/843126.CrossRef

Mander, B. A., Winer, J. R., & Walker, M. P. (2017, April 5). Sleep and human aging. Neuron, 94, 19–36. https://doi.org/10.1016/j.neuron.2017.02.004.

McCleery, J., Cohen, D. A., & Sharpley, A. L. (2014). Pharmacotherapies for sleep disturbances in Alzheimer’s disease. In J. McCleery (Ed.), Cochrane Database of Systematic Reviews (p. CD009178). https://doi.org/10.1002/14651858.CD009178.pub2.

McCrae, C. S., Curtis, A. F., Williams, J. M., Dautovich, N. D., McNamara, J. P. H., Stripling, A., et al. (2018). Efficacy of brief behavioral treatment for insomnia in older adults: Examination of sleep, mood, and cognitive outcomes. Sleep Medicine, 51, 153–166. https://doi.org/10.1016/j.sleep.2018.05.018.CrossRefPubMedPubMedCentral

McCrae, C. S., & Lichstein, K. L. (2001). Secondary insomnia: Diagnostic challenges and intervention opportunities. Sleep Medicine Reviews, 5(1), 47–61. https://doi.org/10.1053/smrv.2000.0146.CrossRefPubMed

McKinnon, A., Terpening, Z., Hickie, I. B., Batchelor, J., Grunstein, R., Lewis, S. J. G., et al. (2014). Prevalence and predictors of poor sleep quality in mild cognitive impairment. Journal of Geriatric Psychiatry and Neurology, 27(3), 204–211. https://doi.org/10.1177/0891988714527516.CrossRefPubMed

Miner, B., & Kryger, M. H. (2017). Sleep in the aging population. Sleep Medicine Clinics, 12(1), 31–38. https://doi.org/10.1016/j.jsmc.2016.10.008.

Morin, C. M., Bastien, C., Guay, B., Radouco-Thomas, M., Leblanc, J., & Vallieres, A. (2004). Randomized clinical trial of supervised tapering and cognitive behavior therapy to facilitate benzodiazepine discontinuation in older adults with chronic insomnia. The American Journal of Psychiatry, 161(2), 332–342. https://doi.org/10.1176/appi.ajp.161.2.332.CrossRefPubMed

Morin, C. M., Colecchi, C., Stone, J., Sood, R., & Brink, D. (1999). Behavioral and pharmacological therapies for late-life insomnia a randomized controlled trial. JAMA, 281(11), 991–999. Retrieved from https://jamanetwork.com/.

Morin, C. M., Vallières, A., Guay, B., Ivers, H., Savard, J., Mérette, C., et al. (2009). Cognitive behavioral therapy, singly and combined with medication, for persistent insomnia: A randomized controlled trial. JAMA – Journal of the American Medical Association, 301(19), 2005–2015. https://doi.org/10.1001/jama.2009.682.CrossRefPubMed

Nadorff, M. R., Drapeau, C. W., & Pigeon, W. R. (2018). Psychiatric illness and sleep in older adults. Sleep Medicine Clinics, 13(1), 81–91. https://doi.org/10.1016/j.jsmc.2017.09.008.CrossRefPubMed

Nadorff, M. R., Fiske, A., Sperry, J. A., Petts, R., & Gregg, J. J. (2013a). Insomnia symptoms, nightmares, and suicidal ideation in older adults. Journals of Gerontology – Series B Psychological Sciences and Social Sciences, 68(2), 145–152. https://doi.org/10.1093/geronb/gbs061.CrossRef

Nadorff, M. R., Nazem, S., & Fiske, A. (2013b). Insomnia symptoms, nightmares, and suicide risk: Duration of sleep disturbance matters. Suicide and Life-Threatening Behavior, 43(2), 139–149. https://doi.org/10.1111/sltb.12003.CrossRefPubMed

Nadorff, M. R., Porter, B., Rhoades, H. M., Greisinger, A. J., Kunik, M. E., & Stanley, M. A. (2014). Bad dream frequency in older adults with generalized anxiety disorder: Prevalence, correlates, and effect of cognitive behavioral treatment for anxiety. Behavioral Sleep Medicine, 12(1), 28–40. https://doi.org/10.1080/15402002.2012.755125.CrossRefPubMed

Ng, K. T., Teoh, W. Y., & Khor, A. J. (2020). The effect of melatonin on delirium in hospitalised patients: A systematic review and meta-analyses with trial sequential analysis. Journal of Clinical Anesthesia, 59, 74–81. https://doi.org/10.1016/j.jclinane.2019.06.027.CrossRefPubMed

Olsen, C., Pedersen, I., Bergland, A., Enders-Slegers, M. J., Jøranson, N., Calogiuri, G., et al. (2016). Differences in quality of life in home-dwelling persons and nursing home residents with dementia – A cross-sectional study. BMC Geriatrics, 16(1). https://doi.org/10.1186/s12877-016-0312-4.

Riemann, D., Baglioni, C., Bassetti, C., Bjorvatn, B., Dolenc Groselj, L., Ellis, J. G., et al. (2017). European guideline for the diagnosis and treatment of insomnia. Journal of Sleep Research, 26(6), 675–700. https://doi.org/10.1111/jsr.12594.CrossRefPubMed

Scharf, M., Rogowski, R., Hull, S., Cohn, M., Mayleben, D., Feldman, N., et al. (2008). Efficacy and safety of doxepin 1 mg, 3 mg, and 6 mg in elderly patients with primary insomnia: A randomized, double-blind, placebo-controlled crossover study. The Journal of Clinical Psychiatry, 69(10), 1557–1564. https://doi.org/10.4088/jcp.v69n1005.CrossRefPubMed

Schennach, R., Feige, B., Riemann, D., Heuser, J., & Voderholzer, U. (2019). Pre- to post-inpatient treatment of subjective sleep quality in 5,481 patients with mental disorders: A longitudinal analysis. Journal of Sleep Research, 28(4). https://doi.org/10.1111/jsr.12842.

Shen, Y., Yan, J., & Cai, G. (2019). High bright light therapy may reduce delirium incidence in critically ill patients. Intensive Care Medicine, 45(5), 755–756. https://doi.org/10.1007/s00134-019-05585-2.CrossRefPubMed

Siebern, A. T., & Manber, R. (2011). New developments in cognitive behavioral therapy as the first-line treatment of insomnia. Psychology Research and Behavior Management, 4, 21–28. https://doi.org/10.2147/prbm.s10041.CrossRefPubMedPubMedCentral

Sivertsen, B., Omvik, S., Pallesen, S., Bjorvatn, B., Havik, O. E., Kvale, G., et al. (2006). Cognitive behavioral therapy vs zopiclone for treatment of chronic primary insomnia in older adults a randomized controlled trial. JAMA, 295(24), 2851–2858.CrossRef

Smagula, S. F., Stone, K. L., Fabio, A., & Cauley, J. A. (2016). Risk factors for sleep disturbances in older adults: Evidence from prospective studies. Sleep Medicine Reviews, 25, 21–30. https://doi.org/10.1016/j.smrv.2015.01.003.CrossRefPubMed

Suzuki, K., Miyamoto, M., & Hirata, K. (2017). Sleep disorders in the elderly: Diagnosis and management. Journal of General and Family Medicine, 18(2), 61–71. https://doi.org/10.1002/jgf2.27.CrossRefPubMedPubMedCentral

Swaab, D. F., Fliers, E., & Partiman, T. S. (1985). The suprachiasmatic nucleus of the human brain in relation to sex, age and senile dementia. Brain Research, 342(1), 37–44. https://doi.org/10.1016/0006-8993(85)91350-2.CrossRefPubMed

Van Someren, E. J. W., Riemersma, R. F., & Swaab, D. F. (2005). Licht op het slaap-waakritme bij ouderen en op dementie. Tijdschrift Voor Psychiatrie, 47(1), 29–38.

Wang, J. L., Lim, A. S., Chiang, W.-Y., Hsieh, W.-H., Lo, M.-T., Schneider, J. A., et al. (2015). Suprachiasmatic neuron numbers and rest-activity circadian rhythms in older humans. Annals of Neurology, 78(2), 317–322. https://doi.org/10.1002/ana.24432.CrossRefPubMedPubMedCentral

Wennberg, A. M. V, Wu, M. N., Rosenberg, P. B., & Spira, A. P. (2017). Sleep disturbance, cognitive decline, and dementia: A review. https://doi.org/10.1055/s-0037-1604351.

Winkler, A., & Rief, W. (2015). Effect of placebo conditions on polysomnographic parameters in primary insomnia: A meta-analysis. Sleep, 38(6), 925–931. https://doi.org/10.5665/sleep.4742.CrossRefPubMedPubMedCentral

Titel: Slaapstoornissen bij ouderen
Auteurs: dr. Julia van den Berg
dr. Viona Wijnen
dr. Saskia van Liempt
Uitgeverij: Bohn Stafleu van Loghum
Boek: Slaapstoornissen in de psychiatrie
Print ISBN: 978-90-368-2523-8

Elektronisch ISBN: 978-90-368-2524-5

Copyright: 2021
DOI: https://doi.org/10.1007/978-90-368-2524-5_21

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Samenvatting

Log in om toegang te krijgen